Håkon Bøås

Norwegian Institute of Public Health

Norway

Research Interests

Explore related searches

Professors in Norway

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Jacob Dag Berild

Norwegian Institute of Public Health

NORWAY

View details

Pascale Renée Cyr

Norwegian Institute of Public Health

NORWAY

View details

Lesly María Acosta Argueta

Profesora lectora

Universitat Politècnica de Catalunya

SPAIN

View details

Lance Presser

Rijksinstituut voor Volksgezondheid en Milieu

NETHERLANDS

View details

Hinta Meijerink

Norwegian Institute of Public Health

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Håkon Bøås

Research Interests

Explore related searches

Contact this professor

Articles (18)

Changed epidemiology of influenza and RSV hospitalizations after the emergence of SARS-CoV-2 in Norway, 2017–2024

Surveillance of severe acute respiratory infections associated with SARS-CoV-2, influenza virus and RSV using ICD-10 codes: a case definition accuracy study across five European countries, 2021 to 2023

Registry‐Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021–2024

Healthcare associated COVID-19 Infections and Mortality

Effectiveness of one and two doses of acellular pertussis vaccines against laboratory-confirmed pertussis requiring hospitalisation in infants: Results of the PERTINENT sentinel surveillance system in six EU/EEA countries, December 2015 – December 2019

Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024

No association between disease severity and respiratory syncytial virus subtypes RSV-A and RSV-B in hospitalized young children in Norway

Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022

Estimation of the number of RSV-associated hospitalisations in adults in the European Union

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022

Stroke After SARS-CoV-2 mRNA Vaccine: A Nationwide Registry Study

New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic

Short-term safety of COVID-19 mRNA vaccines with respect to all-cause mortality in the older population in Norway

The burden of hospital-attended influenza in Norwegian children

Risk factors associated with severe disease in respiratory syncytial virus infected children under 5 years of age

COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway

Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway

Age-Specific Estimates of Respiratory Syncytial Virus-Associated Hospitalizations in 6 European Countries: A Time Series Analysis

Collaborators (5)

Jacob Dag Berild

Pascale Renée Cyr

Lesly María Acosta Argueta

Lance Presser

Hinta Meijerink

Make your next move.